Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 12 > 11
Other dates of the month:
- Jack Ma’s Biggest E-Commerce Rival Is Coming for Amazon
- 17 Frugal Reminders To Tell Yourself Each Week
- 9 Costco Bulk Food Items That Are Cheaper Than Takeout
- Social Security: With Cuts and No Cuts, Here’s What Your Benefit Should Be in 10 Years
- Maine Condo Project to Offer Turnkey Restoration Hardware Units
- PPB Group Berhad's (KLSE:PPB) top owners are private companies with 56% stake, while 26% is held by institutions
- Britain's M&G invests in crypto derivatives platform GFO-X
- Three Days Left To Buy Bonia Corporation Berhad (KLSE:BONIA) Before The Ex-Dividend Date
- Should You Be Adding PGF Capital Berhad (KLSE:PGF) To Your Watchlist Today?
- GLOBAL MARKETS-Asian stocks brace for central bank bonanza
- Wall St notches new 2023 closing highs, gold slides ahead of CPI, Fed
- Only Three Days Left To Cash In On Padini Holdings Berhad's (KLSE:PADINI) Dividend
- PRESS DIGEST- Financial Times - Dec. 11
- With 44% ownership, Kinergy Advancement Berhad (KLSE:KAB) insiders have a lot at stake
- CGTN: China, Vietnam eye closer people-to-people bonds
- We Wouldn't Be Too Quick To Buy George Kent (Malaysia) Berhad (KLSE:GKENT) Before It Goes Ex-Dividend
- Hextar Industries Berhad's (KLSE:HEXIND) top owners are private companies with 56% stake, while 33% is held by individual investors
- Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
- Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
- New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma
- Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes
- ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma
- Latest Data of InnoCare’s Oncology Pipelines Presented at the 65th Annual Meeting of ASH
- Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone
- MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
- Investors Could Be Concerned With CTOS Digital Berhad's (KLSE:CTOS) Returns On Capital
- Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
- Sigma Healthcare Limited's (ASX:SIG) top owners are individual investors with 37% stake, while 36% is held by institutions
- Can Chin Hin Group Berhad's (KLSE:CHINHIN) ROE Continue To Surpass The Industry Average?
- PRESS DIGEST-British Business - Dec 11
- Xinhua Silk Road: China's Bama Tea shares tea culture and seeks cooperation at Belt and Road forum
- FOREX-Dollar steady with US inflation, Fed meeting eyed; yuan heavy
- QBE Insurance Group (ASX:QBE) pulls back 5.3% this week, but still delivers shareholders favorable 17% CAGR over 3 years
- New Operation HOPE Research Finds That Financial Literacy Resources, Tools & Coaching Services Are Key Drivers of Optimism Despite Uncertain Economic Times
- Shareholders of ContextLogic Demand More Shareholder Representation on the Board
- ‘The people have spoken’: Elon Musk restores the X account of conspiracy theorist Alex Jones after poll
- Mortgage rates are sinking, but don't try to time the housing market by waiting for them to fall further, BofA exec says
- Plantations International Receives PEFC Certification
- Redefining Reliability, Geberit Extends Spare Parts Availability to 50 Years for Concealed Cisterns and Actuator Plates
- Boosting Business Acumen: Chicago Booth’s Executive Education Program in Finance Workshop for Non-Financial Leaders–Available in Hong Kong and Chicago
- The 2023 Forbes China Jiefangbei Forum: Chongqing's Rising Global Competitiveness and Urban Innovation
- UK PM Sunak battles to unite divided party in pivotal week
- Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
- InfiRay Plans to Detail the World's Smallest Thermal Camera P2 Pro at CES 2024
- Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan's Best Global Brands
- Global Times: TV drama 'Welcome to Milele' represents decades-old China-Africa medical aid cooperation
- Datasonic Group Berhad (KLSE:DSONIC) most popular amongst individual investors who own 31%, insiders hold 26%
- GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity
- Senator Warren cries antitrust in Beeper Mini affair
- Musk Restores Alex Jones’s X Account After Vote From Users